Deal Library / Pharma BD Deal Intelligence

Mylan Inc. — Pharma Deals

The Pharma Closeout tracks 5 deals, $8.7B in disclosed deal value, 5 with a post-close Outcome Score for Mylan Inc..

Median Critic Score: 88 · Median Outcome Score: 56

All 5 deals

Mylan Inc. / Theravance Biopharma, Inc. (TD-4208 program) — 2015 · $265M · Largely worked — most objectives met.
Mylan Inc. / Bioniche Pharma Holdings Limited — 2010 · $550M · Largely worked — most objectives met.
Mylan Inc. / Famy Care Limited (women's healthcare businesses) — 2015 · $800M · Mixed — partial payoff, real shortfalls.
Mylan Inc. / Agila Specialties (Strides Arcolab) — 2013 · $1.8B · Mixed — partial payoff, real shortfalls.
Mylan Inc. / Abbott Laboratories (non-U.S. developed-markets specialty and branded generics business) — 2014 · $5.3B · Underwhelmed — fell short of the thesis.